Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia (Q33710581)

28 July 2017

Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia (English)

1 reference

28 July 2017

endometrial carcinoma

1 reference

9

Nilanjan Chatterjee

1 reference

28 July 2017

James V Lacey

1

1 reference

28 July 2017

Mark E Sherman

2

1 reference

28 July 2017

Brenda B Rush

3

1 reference

28 July 2017

Brigitte M Ronnett

4

1 reference

28 July 2017

Olga B Ioffe

5

1 reference

28 July 2017

Máire A Duggan

6

1 reference

28 July 2017

Andrew G Glass

7

1 reference

28 July 2017

Douglas A Richesson

8

1 reference

28 July 2017

Bryan Langholz

10

1 reference

28 July 2017

language of work or name

English

0 references

publication date

11 January 2010

1 reference

Journal of Clinical Oncology

28 July 2017

1 reference

28 July 2017

28

1 reference

28 July 2017

5

1 reference

28 July 2017

788-792

1 reference

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

My approach to the interpretation of endometrial biopsies and curettings

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Building a research consortium of large health systems: the Cancer Research Network.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

The management of endometrial hyperplasia: an evaluation of current practice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Endometrial hyperplasia/adenocarcinoma. a conventional approach

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Endometrial hyperplasia: is it time for a quantum leap to a new classification?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Problems in the differential diagnosis of endometrial hyperplasia and carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Estimation of absolute risk from nested case-control data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Sampling strategies in nested case-control studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Atypical Endometrial Hyperplasia: Grounds for Possible Misdiagnosis of Endometrial Adenocarcinoma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Optimal management of endometrial hyperplasia

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2834395

Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years

30 October 2018

1 reference

12 December 2020

The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group

1 reference

12 December 2020

ACOG Practice Bulletin #65: Management of Endometrial Cancer

1 reference

12 December 2020

Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia

1 reference

12 December 2020

Natural history of endometrial hyperplasia. Study of 77 patients

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2009.24.1315

1 reference

28 July 2017

1 reference

28 July 2017

1 reference